NCT00612040 - Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes | Biotech Hunter

Enrollment

178

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin degludec

Formulation 1: Treat-to-target dose titration scheme, injection s.c. (under the skin), once daily

DRUG

insulin degludec

Formulation 2: Treat-to-target dose titration scheme, injection s.c. (under the skin), once daily

DRUG

insulin glargine

Treat-to-target dose titration scheme, injection s.c., once daily

DRUG

insulin aspart

Treat-to-target dose titration scheme, injection s.c. (under the skin), 3 times daily

Trial Locations (33)

2228

Novo Nordisk Investigational Site, Miranda

2408

Novo Nordisk Investigational Site, Elverum

2500

Novo Nordisk Investigational Site, Wollongong

3135

Novo Nordisk Investigational Site, East Ringwood

3220

Novo Nordisk Investigational Site, Geelong

4011

Novo Nordisk Investigational Site, Stavanger

4604

Novo Nordisk Investigational Site, Kristiansand

5021

Novo Nordisk Investigational Site, Bergen

5035

Novo Nordisk Investigational Site, Keswick

20782

Novo Nordisk Investigational Site, Hyattsville

22607

Novo Nordisk Investigational Site, Hamburg

37404

Novo Nordisk Investigational Site, Chattanooga

50314

Novo Nordisk Investigational Site, Des Moines

55545

Novo Nordisk Investigational Site, Bad Kreuznach

56564

Novo Nordisk Investigational Site, Neuwied

63739

Novo Nordisk Investigational Site, Aschaffenburg

66386

Novo Nordisk Investigational Site, Saint Ingbert

75230

Novo Nordisk Investigational Site, Dallas

75231

Novo Nordisk Investigational Site, Dallas

94598

Novo Nordisk Investigational Site, Walnut Creek

96814

Novo Nordisk Investigational Site, Honolulu

98057

Novo Nordisk Investigational Site, Renton

83404-7596

Novo Nordisk Investigational Site, Idaho Falls

01219

Novo Nordisk Investigational Site, Dresden

06679

Novo Nordisk Investigational Site, Hohenmölsen

NO-5012

Novo Nordisk Investigational Site, Bergen

0586

Novo Nordisk Investigational Site, Oslo

441 83

Novo Nordisk Investigational Site, Alingsås

651 85

Novo Nordisk Investigational Site, Karlstad

221 85

Novo Nordisk Investigational Site, Lund

112 81

Novo Nordisk Investigational Site, Stockholm

182 88

Novo Nordisk Investigational Site, Stockholm

901 85

Novo Nordisk Investigational Site, Umeå